Targeting by cmHsp70.1-antibody coated and survivin miRNA plasmid loaded nanoparticles to radiosensitize glioblastoma cells

Journal of Controlled Release

Volumn 172, Issue 1, 2013, Pages 201-206

  Gaca, Sebastian ^a   Reichert, Sebastian ^b   Multhoff, Gabriele ^c   Wacker, Matthias ^a   Hehlgans, Stephanie ^b   Botzler, Claus ^c   Gehrmann, Matthias ^c   Rödel, Claus ^b   Kreuter, Jörg ^a   Rödel, Franz ^b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Expression plasmids; Glioblastoma; HSA nanoparticles; Radiosensitization; RNA interference; Survivin

Indexed keywords

EXPRESSION PLASMIDS; GLIOBLASTOMAS; HSA NANOPARTICLES; RADIO-SENSITIZATION; RNA INTERFERENCE; SURVIVIN;

ANTIBODIES; CELLS; CYTOLOGY; DNA; ENZYME INHIBITION; NANOPARTICLES; RADIOTHERAPY;

RNA;

CASPASE 3; CASPASE 7; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70 ANTIBODY; HUMAN SERUM ALBUMIN; MACROGOL; MICRORNA; MONOCLONAL ANTIBODY; NANOPARTICLE; PROPIONIC ACID; SURVIVIN; UNCLASSIFIED DRUG;

ANTIGEN BINDING; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; GLIOBLASTOMA; HUMAN; HUMAN CELL; IONIZING RADIATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIZATION; SURFACE CHARGE;

EXPRESSION PLASMIDS; GLIOBLASTOMA; HSA NANOPARTICLES; RADIOSENSITIZATION; RNA INTERFERENCE; SURVIVIN;

ANTIBODIES, IMMOBILIZED; CELL LINE, TUMOR; GENE KNOCKDOWN TECHNIQUES; GENETIC THERAPY; GLIOBLASTOMA; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICRORNAS; NANOPARTICLES; PLASMIDS;

EID: 84884233263     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.08.020     Document Type: Article

References (43)

1. C. Adamson, O.O. Kanu, A.I. Mehta, C. Di, N. Lin, A.K. Mattox, and D.D. Bigner Glioblastoma multiforme: a review of where we have been and where we are going Expert Opin. Investig. Drugs 18 2009 1061 1083
2. J. Gerstein, K. Franz, J.P. Steinbach, V. Seifert, I. Fraunholz, C. Weiss, and C. Rodel Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma Radiother. Oncol. 97 2010 382 386
3. G. Minniti, D. Amelio, M. Amichetti, M. Salvati, R. Muni, A. Bozzao, G. Lanzetta, S. Scarpino, A. Arcella, and R.M. Enrici Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide Radiother. Oncol. 97 2010 377 381
4. S. Bao, Q. Wu, R.E. McLendon, Y. Hao, Q. Shi, A.B. Hjelmeland, M.W. Dewhirst, D.D. Bigner, and J.N. Rich Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 444 2006 756 760 (Pubitemid 44949604)
5. R.Y. Bai, V. Staedtke, and G.J. Riggins Molecular targeting of glioblastoma: drug discovery and therapies Trends Mol. Med. 17 2011 301 312
6. L. Brannon-Peppas, B. Ghosn, K. Roy, and K. Cornetta Encapsulation of nucleic acids and opportunities for cancer treatment Pharm. Res. 24 2007 618 627 (Pubitemid 46411970)
7. I. Steinhauser, B. Spankuch, K. Strebhardt, and K. Langer Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells Biomaterials 27 2006 4975 4983 (Pubitemid 43866920)
8. B. Spankuch, I. Steinhauser, H. Wartlick, E. Kurunci-Csacsko, K.I. Strebhardt, and K. Langer Downregulation of Plk1 expression by receptor-mediated uptake of antisense oligonucleotide-loaded nanoparticles Neoplasia 10 2008 223 234 (Pubitemid 351328583)
9. K. Ulbrich, T. Knobloch, and J. Kreuter Targeting the insulin receptor: nanoparticles for drug delivery across the blood-brain barrier (BBB) J. Drug Target. 19 2011 125 132
10. M. Sherman, and G. Multhoff Heat shock proteins in cancer Ann. N. Y. Acad. Sci. 1113 2007 192 201 (Pubitemid 350015025)
11. G. Multhoff, and L.E. Hightower Distinguishing integral and receptor-bound heat shock protein 70 (Hsp70) on the cell surface by Hsp70-specific antibodies Cell Stress Chaperones 16 2011 251 255
12. S. Stangl, M. Gehrmann, J. Riegger, K. Kuhs, I. Riederer, W. Sievert, K. Hube, R. Mocikat, R. Dressel, E. Kremmer, A.G. Pockley, L. Friedrich, L. Vigh, A. Skerra, and G. Multhoff Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody Proc. Natl. Acad. Sci. U. S. A. 108 2011 733 738
13. M. Gehrmann, D. Schilling, M. Molls, and G. Multhoff Radiation induced stress proteins Int. J. Clin. Pharmacol. Ther. 48 2010 492 493
14. D.C. Altieri Survivin, cancer networks and pathway-directed drug discovery Nat. Rev. Cancer 8 2008 61 70
15. F. Rodel, T. Sprenger, B. Kaina, T. Liersch, C. Rodel, S. Fulda, and S. Hehlgans Survivin as a prognostic/predictive marker and molecular target in cancer therapy Curr. Med. Chem. 19 2012 3679 3688
16. F. Rodel, S. Reichert, T. Sprenger, U.S. Gaipl, J. Mirsch, T. Liersch, S. Fulda, and C. Rodel The role of survivin for radiation oncology: moving beyond apoptosis inhibition Curr. Med. Chem. 18 2011 191 199
17. S. Gaca, S. Reichert, C. Rodel, F. Rodel, and J. Kreuter Survivin-miRNA-loaded nanoparticles as auxiliary tools for radiation therapy: preparation, characterisation, drug release, cytotoxicity and therapeutic effect on colorectal cancer cells J. Microencapsul. 29 2012 685 694
18. I. Steinhauser, K. Langer, K. Strebhardt, and B. Spankuch Uptake of plasmid-loaded nanoparticles in breast cancer cells and effect on Plk1 expression J. Drug Target. 17 2009 627 637
19. M.G. Anhorn, S. Wagner, J. Kreuter, K. Langer, and H. von Briesen Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles Bioconjug. Chem. 19 2008 2321 2331
20. J. Kufleitner, S. Wagner, F. Worek, H. von Briesen, and J. Kreuter Adsorption of obidoxime onto human serum albumin nanoparticles: drug loading, particle size and drug release J. Microencapsul. 27 2010 506 513
21. K. Ulbrich, T. Hekmatara, E. Herbert, and J. Kreuter Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB) Eur. J. Pharm. Biopharm. 71 2009 251 256
22. K. Langer, M.G. Anhorn, I. Steinhauser, S. Dreis, D. Celebi, N. Schrickel, S. Faust, and V. Vogel Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation Int. J. Pharm. 347 2008 109 117 (Pubitemid 350180317)
23. F. Fazlollahi, A. Sipos, Y.H. Kim, S.F. Hamm-Alvarez, Z. Borok, K.J. Kim, and E.D. Crandall Translocation of PEGylated quantum dots across rat alveolar epithelial cell monolayers Int. J. Nanomed. 6 2011 2849 2857
24. Q. Lin, J. Chen, K.K. Ng, W. Cao, Z. Zhang, and G. Zheng Imaging the cytosolic drug delivery mechanism of HDL-like nanoparticles Pharm. Res. 2013 10.1007/s11095-013-1046-z (in press).
25. S. Reichert, C. Rodel, J. Mirsch, P.N. Harter, M.T. Tomicic, M. Mittelbronn, B. Kaina, and F. Rodel Survivin inhibition and DNA double-strand break repair: a molecular mechanism to overcome radioresistance in glioblastoma Radiother. Oncol. 101 2011 51 58
26. F. Rodel, J. Hoffmann, L. Distel, M. Herrmann, T. Noisternig, T. Papadopoulos, R. Sauer, and C. Rodel Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer Cancer Res. 65 2005 4881 4887 (Pubitemid 40740827)
27. S. Reichert, V. Reinboldt, S. Hehlgans, T. Efferth, C. Rodel, and F. Rodel A radiosensitizing effect of artesunate in glioblastoma cells is associated with a diminished expression of the inhibitor of apoptosis protein survivin Radiother. Oncol. 103 2012 394 401
28. A. Chakravarti, G.G. Zhai, M. Zhang, R. Malhotra, D.E. Latham, M.A. Delaney, P. Robe, U. Nestler, Q. Song, and J. Loeffler Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms Oncogene 23 2004 7494 7506 (Pubitemid 39389691)
29. R.K. Kanwar, C.H. Cheung, J.Y. Chang, and J.R. Kanwar Recent advances in anti-survivin treatments for cancer Curr. Med. Chem. 17 2010 1509 1515
30. K. Ulbrich, M. Michaelis, F. Rothweiler, T. Knobloch, P. Sithisarn, J. Cinatl, and J. Kreuter Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells Int. J. Pharm. 406 2011 128 134
31. S. Wohlfart, S. Gelperina, and J. Kreuter Transport of drugs across the blood-brain barrier by nanoparticles J. Control Release 161 2012 264 273
32. S. Wohlfart, A.S. Khalansky, S. Gelperina, D. Begley, and J. Kreuter Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier J. Control Release 154 2011 103 107
33. M. Hantschel, K. Pfister, A. Jordan, R. Scholz, R. Andreesen, G. Schmitz, H. Schmetzer, W. Hiddemann, and G. Multhoff Hsp70 plasma membrane expression on primary tumor biopsy material and bone marrow of leukemic patients Cell Stress Chaperones 5 2000 438 442 (Pubitemid 32057495)
34. K. Pfister, J. Radons, R. Busch, J.G. Tidball, M. Pfeifer, L. Freitag, H.J. Feldmann, V. Milani, R. Issels, and G. Multhoff Patient survival by Hsp70 membrane phenotype: association with different routes of metastasis Cancer 110 2007 926 935 (Pubitemid 47257673)
35. S. Stangl, M. Gehrmann, R. Dressel, F. Alves, C. Dullin, G. Themelis, V. Ntziachristos, E. Staeblein, A. Walch, I. Winkelmann, and G. Multhoff In vivo imaging of CT26 mouse tumours by using cmHsp70.1 monoclonal antibody J. Cell. Mol. Med. 15 2011 874 887
36. G. Multhoff Heat shock protein 70 (Hsp70): membrane location, export and immunological relevance Methods 43 2007 229 237 (Pubitemid 47499077)
37. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug Discov. 9 2010 615 627
38. I. Horvath, G. Multhoff, A. Sonnleitner, and L. Vigh Membrane-associated stress proteins: more than simply chaperones Biochim. Biophys. Acta 1778 2008 1653 1664
39. N. Arispe, M. Doh, O. Simakova, B. Kurganov, and A. De Maio Hsc70 and Hsp70 interact with phosphatidylserine on the surface of PC12 cells resulting in a decrease of viability FASEB J. 18 2004 1636 1645 (Pubitemid 39463703)
40. V.L. Vega, W. Charles, and A. De Maio A new feature of the stress response: increase in endocytosis mediated by Hsp70 Cell Stress Chaperones 15 2010 517 527
41. K. Low, M. Wacker, S. Wagner, K. Langer, and H. von Briesen Targeted human serum albumin nanoparticles for specific uptake in EGFR-Expressing colon carcinoma cells Nanomedicine 7 2011 454 463
42. Y. Yang, Y. Gao, L. Chen, Y. Huang, and Y. Li Downregulation of survivin expression and enhanced chemosensitivity of MCF-7 cells to adriamycin by PDMAE/survivin shRNA complex nanoparticles Int. J. Pharm. 405 2011 188 195
43. J. Kreuter, and S. Gelperina Use of nanoparticles for cerebral cancer Tumori 94 2008 271 277 (Pubitemid 351838835)